Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Crystallin: Evidence Summary
Evidence summary for Crystallin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Crystallin overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Cataract biomarker | Tier C | 0 | Validated as diagnostic biomarker, not a therapeutic |
| Retinal protection | Tier D | 0 | Animal gene therapy studies only — no human trials |
| Anti-aging therapeutic | Tier D | 0 | No therapeutic development — biomarker research only |
References (3)
- Crystallin in lens biology and pathology — Andley UP . Progress in Retinal and Eye Research (2007)
- Crystallin changes in human cataractous lenses — Pasupuleti N, et al. . Molecular Vision (2013) PMID: 8405188
- Alpha-crystallin overexpression protects retina in mouse model — Yaung J, et al. . Experimental Eye Research (2007)